School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, S637371, Singapore, Singapore.
State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, 4221 Xiangan Road, Xiang'an District, Xiamen, Fujian, 361102, China.
Angew Chem Int Ed Engl. 2024 Aug 12;63(33):e202406843. doi: 10.1002/anie.202406843. Epub 2024 Jul 18.
Uropathogenic Escherichia coli (UPECs) is a leading cause for urinary tract infections (UTI), accounting for 70-90 % of community or hospital-acquired bacterial infections owing to high recurrence, imprecision in diagnosis and management, and increasing prevalence of antibiotic resistance. Current methods for clinical UPECs detection still rely on labor-intensive urine cultures that impede rapid and accurate diagnosis for timely UTI therapeutic management. Herein, we developed a first-in-class near-infrared (NIR) UPECs fluorescent probe (NO-AH) capable of specifically targeting UPECs through its collaborative response to bacterial enzymes, enabling locoregional imaging of UTIs both in vitro and in vivo. Our NO-AH probe incorporates a dual protease activatable moiety, which first reacts with OmpT, an endopeptidase abundantly present on the outer membrane of UPECs, releasing an intermediate amino acid residue conjugated with a NIR hemicyanine fluorophore. Such liberated fragment would be subsequently recognized by aminopeptidase (APN) within the periplasm of UPECs, activating localized fluorescence for precise imaging of UTIs in complex living environments. The peculiar specificity and selectivity of NO-AH, facilitated by the collaborative action of bacterial enzymes, features a timely and accurate identification of UPECs-infected UTIs, which could overcome misdiagnosis in conventional urine tests, thus opening new avenues towards reliable UTI diagnosis and personalized antimicrobial therapy management.
尿路致病性大肠杆菌(UPEC)是尿路感染(UTI)的主要原因,占社区或医院获得性细菌感染的 70-90%,原因是其复发率高、诊断和管理不精确,以及抗生素耐药性不断增加。目前用于临床 UPEC 检测的方法仍然依赖于劳动密集型的尿液培养,这阻碍了快速、准确的诊断,从而无法及时进行 UTI 治疗管理。在此,我们开发了一种首创的近红外(NIR)UPEC 荧光探针(NO-AH),能够通过与细菌酶的协同反应特异性靶向 UPEC,从而能够在体外和体内对 UTI 进行局部成像。我们的 NO-AH 探针包含双蛋白酶激活部分,该部分首先与 OmpT(UPEC 外膜上丰富存在的内肽酶)反应,释放与 NIR 半花菁荧光团偶联的中间氨基酸残基。这种游离片段随后将被 UPEC 周质内的氨肽酶(APN)识别,激活局部荧光,从而可以在复杂的活体环境中对 UTI 进行精确成像。NO-AH 的独特特异性和选择性是由细菌酶的协同作用促成的,能够及时、准确地识别 UPEC 感染的 UTI,克服了传统尿液检测中的误诊,从而为可靠的 UTI 诊断和个性化抗菌治疗管理开辟了新途径。